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Transpulmonary thermodilution-derived cardiac function index
identifies cardiac dysfunction in acute heart failure and septic
patients: an observational study
Abstract
INTRODUCTION: There is limited clinical experience with the single-indicator transpulmonary
thermodilution (pulse contour cardiac output, or PiCCO) technique in critically ill medical patients,
particularly in those with acute heart failure (AHF). Therefore, we compared the cardiac function of
patients with AHF or sepsis using the pulmonary artery catheter (PAC) and the PiCCO technology.
METHODS: This retrospective observational study was conducted in the medical intensive care unit of
a university hospital. Twelve patients with AHF and nine patients with severe sepsis or septic shock had
four simultaneous hemodynamic measurements by PAC and PiCCO during a 24-hour observation
period. Comparisons between groups were made with the use of the Mann-Whitney U test. Including all
measurements, correlations between data pairs were established using linear regression analysis and are
expressed as the square of Pearson's correlation coefficients (r2). RESULTS: Compared to septic
patients, AHF patients had a significantly lower cardiac index, cardiac function index (CFI), global
ejection fraction, mixed venous oxygen saturation (SmvO2) and pulmonary vascular permeability index,
but higher pulmonary artery occlusion pressure. All patients with a CFI less than 4.5 per minute had an
SmvO2 not greater than 70%. In both groups, the CFI correlated with the left ventricular stroke work
index (sepsis: r2 = 0.30, P < 0.05; AHF: r2 = 0.23, P < 0.05) and cardiac power (sepsis: r2 = 0.39, P <
0.05; AHF: r2 = 0.45, P < 0.05). CONCLUSIONS: In critically ill medical patients, assessment of
cardiac function using transpulmonary thermodilution technique is an alternative to the PAC. A low CFI
identifies cardiac dysfunction in both AHF and septic patients.
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Abstract
Introduction There is limited clinical experience with the single-
indicator transpulmonary thermodilution (pulse contour cardiac
output, or PiCCO) technique in critically ill medical patients,
particularly in those with acute heart failure (AHF). Therefore, we
compared the cardiac function of patients with AHF or sepsis
using the pulmonary artery catheter (PAC) and the PiCCO
technology.
Methods This retrospective observational study was conducted
in the medical intensive care unit of a university hospital. Twelve
patients with AHF and nine patients with severe sepsis or septic
shock had four simultaneous hemodynamic measurements by
PAC and PiCCO during a 24-hour observation period.
Comparisons between groups were made with the use of the
Mann-Whitney U test. Including all measurements, correlations
between data pairs were established using linear regression
analysis and are expressed as the square of Pearson's
correlation coefficients (r2).
Results Compared to septic patients, AHF patients had a
significantly lower cardiac index, cardiac function index (CFI),
global ejection fraction, mixed venous oxygen saturation
(SmvO2) and pulmonary vascular permeability index, but higher
pulmonary artery occlusion pressure. All patients with a CFI less
than 4.5 per minute had an SmvO2 not greater than 70%. In both
groups, the CFI correlated with the left ventricular stroke work
index (sepsis: r2 = 0.30, P < 0.05; AHF: r2 = 0.23, P < 0.05) and
cardiac power (sepsis: r2 = 0.39, P < 0.05; AHF: r2 = 0.45, P <
0.05).
Conclusions In critically ill medical patients, assessment of
cardiac function using transpulmonary thermodilution technique
is an alternative to the PAC. A low CFI identifies cardiac
dysfunction in both AHF and septic patients.
Introduction
Several studies have suggested that there is no clear benefit,
or that there may even be harm, in using a pulmonary artery
catheter (PAC) in critically ill patients [1-4]. As a result, the use
of PAC decreased substantially over the last decade [5]. How-
ever, PAC is still recommended for the hemodynamic monitor-
ing of critically ill patients with heart failure [6] because it
allows the assessment of the pulmonary artery occlusion pres-
sure (PAOP), which may provide information on left ventricular
function [7]. As an alternative to the more invasive PAC, the
use of the transpulmonary thermodilution method (pulse con-
tour cardiac output, or PiCCO) has been suggested [8]. The
PiCCO monitor measures cardiac output (CO) and the global
end-diastolic volume indexed for body surface area (GEDVI)
as well as parameters of cardiac performance such as the car-
diac function index (CFI) and the global ejection fractionPage 1 of 10
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AHF: acute heart failure; ALI/ARDS: acute lung injury/acute respiratory distress syndrome; CFI: cardiac function index; CI: cardiac output indexed for 
body surface area; CO: cardiac output; CP: cardiac power; DSt: exponential downslope time; ELWI: extravascular lung water indexed for predicted 
body weight; EVLW: extravascular lung water; GEDV: global end-diastolic volume; GEDVI: global end-diastolic volume indexed for body surface area; 
GEF: global ejection fraction; ICU: intensive care unit; IQR: interquartile range; ITTV: intrathoracic thermal volume; LVSWI: left ventricular stroke work 
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(EVLW) and calculates the pulmonary vascular permeability
index (PVPI) [9-11], which allows the differentiation between
a hydrostatic and a permeability type of pulmonary edema
[12,13]. Volumetric parameters better estimate preload than
central venous pressure or PAOP [8,10,11,14], and EVLW
monitoring is of prognostic relevance [15-18]. A recent study
suggested that guiding fluid and catecholamine therapy by an
algorithm based on GEDVI and EVLW reduces postoperative
vasopressor and catecholamine requirements in cardiac sur-
gery patients [19].
The PiCCO method has been validated mainly in surgical
patients and, to a lesser extent, in patients with sepsis [14,20-
22]. However, there is still limited clinical experience with
PiCCO-derived parameters of cardiac function and volume
status in critically ill medical patients, particularly in those with
acute heart failure (AHF) [8]. Therefore, we retrospectively
analysed a series of simultaneous measurements by PiCCO
and PAC in patients with AHF, severe sepsis, or septic shock.
Materials and methods
Study design
The study was performed at the 12-bed medical intensive care
unit (ICU) of the University Hospital Zurich, Switzerland.
Approval was given by our Institutional Review Board. Due to
the retrospective nature of the analysis, the need for informed
consent was waived. Twenty-one patients (15 males and 6
females) with circulatory failure monitored with a PAC were
included in the study. Treatment was directed by the clinicians
in charge of the patients. In 17 patients (81%), PAC was
inserted within 1 day after ICU admission. After initial hemody-
namic stabilisation but before removal of the PAC, the arterial
line was switched to a PiCCO catheter in order to have less
invasive continuous monitoring of CO for vasopressor wean-
ing and fluid management. This provided a unique opportunity
of simultaneous monitoring with the two methods during a 24-
hour period. During this period, the dosage of vasoactive
drugs was progressively decreased and volume was substi-
tuted or removed according to the clinical treatment strategy.
Simultaneous recordings started 2 days (interquartile range
[IQR] 1 to 4 days) after ICU admission. In each patient, four
consecutive measurements were performed before PAC
removal. Median (IQR) time intervals from baseline to the sec-
ond and third measurements were 5 (4 to 8) and 13 (9 to 16)
hours, respectively. All four measurements were realised after
19 (14 to 22) hours. A total of 84 simultaneous hemodynamic
measurements were recorded and finally analysed.
Patient characteristics
Severe sepsis was defined according to the published guide-
lines as systemic inflammatory response syndrome with infec-
tion associated with organ dysfunction [23]. AHF was
diagnosed in the presence of an underlying heart disease and
congestive heart failure, pulmonary edema, or cardiogenic
shock [6]. Diagnosis of AHF was based on clinical signs of
congestion (dyspnea, orthopnea, rales, or elevated jugular
venous pressure), low CO with organ hypoperfusion, and bilat-
eral alveolar consolidations on chest x-ray. Echocardiography
and coronary angiography were performed only when clinically
indicated. The severity of illness was described by the Simpli-
fied Acute Physiology Score (SAPS II) as calculated with the
worst values within 24 hours following ICU admission [24].
AHF and severe sepsis or septic shock were diagnosed in 12
and 9 patients, respectively. Baseline characteristics on ICU
admission are shown in Table 1. Coronary heart disease was
present in 7 patients with AHF. Other underlying heart dis-
eases included dilatative cardiomyopathy (n = 2), non-com-
paction cardiomyopathy (n = 1), valvular heart disease (n = 1),
and congenital heart disease (n = 1). Cardiac imaging by
echocardiography or coronary angiography or both was avail-
able in all heart failure patients except in two with known
ischemic heart disease. The septic patients suffered from
proven bacterial infection, namely pneumonia (n = 6), abdom-
inal infection (n = 1), urogenital tract infection (n = 1), and
puerperal sepsis (n = 1). Twelve patients (57%) required nore-
pinephrine (0.1 to 0.3 μg/kg per minute), 13 patients (62%)
needed inotropic support with dobutamine (1.5 to 6 μg/kg per
minute), milrinone, or levosimendan, and 6 patients (29%)
received intravenous vasodilatators such as nitroglycerin or
nesiritide. Furthermore, 16 patients (76%) were mechanically
ventilated, and 11 patients (52%) had renal replacement ther-
apy by continuous veno-venous hemofiltration.
Hemodynamic measurements
A continuous CO thermodilution PAC (model VIP 139F75;
Edwards Lifesciences LLC, Irvine, CA, USA) was inserted via
a central vein into the right pulmonary artery. Correct place-
ment of the catheter was checked by appropriate pressure
traces and fluoroscopy. The PAC was used for measurements
of pulmonary artery pressure, PAOP, and cardiac index. Spe-
cial care was taken to define the zero reference at midchest
level and to perform measurements at end-expiration. Contin-
uous assessment of CO was measured using the modified
thermodilution technique provided by the PAC manufacturer
and described elsewhere [25,26].
A thermister-tipped arterial PiCCO catheter (Pulsiocath 5F,
20 cm, PV2015L20; Pulsion Medical Systems AG, Munich,
Germany) was placed in the descending aorta and connected
to a bedside PiCCO plus monitor. Cardiac index and volumet-
ric variables were measured with the single-indicator transpul-
monary thermodilution technique. The PiCCO values were
obtained by repeated injections of 15- or 20-mL boluses of
ice-cold normal saline via a central line. The mean value of
three consecutive measurements was used for analysis. If the
difference between the three obtained values for cardiac index
was greater than 10%, two additional measurements werePage 2 of 10
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measurements was used.
By means of the thermodilution curve, the PiCCO calculates
CO by the modified Stewart-Hamilton equation, the mean
transit time (MTt), and the exponential downslope time (DSt)
of the curve. The product of CO times MTt gives the intratho-
racic thermal volume (ITTV) [12,27]. The product of CO times
the DSt gives the pulmonary thermal volume (PTV) [12,28,29].
The difference between ITTV and PTV is called global end-
diastolic volume (GEDV), or GEDVI if indexed for the body sur-
face area.
Stroke volume (SV) is calculated by dividing CO by heart rate.
A 'global' ejection fraction (GEF) can be obtained by dividing
SV by a quarter of GEDV. Similarly, dividing CO by the preload
parameter GEDV gives an indicator of cardiac systolic func-
tion, the so-called CFI. Both GEF and CFI may provide infor-
mation on left ventricular systolic function [30]. In patients with
shock and multi-organ failure, GEF and CFI correlated closely
with left ventricular fractional area of change using echocardi-
ography [30].
The PiCCO method and definitions of intrathoracic blood vol-
ume and EVLW are described in more detail elsewhere [31].
For this study, EVLW was indexed to predicted body weight
(ELWI), as proposed by Phillips and colleagues [16].
The ratio of EVLW to pulmonary blood volume is used as an
index of pulmonary vascular permeability (PVPI). Additionally,
we calculated the ratio of EVLW indexed for body weight to
GEDVI (that is, ELWI/GEDVI × 102) as another index of pul-
monary vascular permeability [13].
In addition to mean arterial pressure (MAP), heart rate, contin-
uous CO, and right atrial pressure, the following hemodynamic
parameters were simultaneously recorded four times in each
patient: cardiac index by both methods, mixed venous oxygen
saturation (SmvO2), left ventricular stroke work index (LVSWI),
PAOP, GEDVI, CFI, GEF, ELWI, and PVPI. For each record-
ing, all variables were determined within 10 minutes. LVSWI
was calculated by the formula SVI × (MAP – PAOP) × 0.0136,
where SVI denotes SV index (SV divided by body surface
area). For comparison purposes, we also calculated cardiac
power (CP) using the formula CP = MAP × CO/451. The CP
has been described as a valuable marker of outcome in
patients with cardiogenic shock [32-34]. Definitions are pro-
vided in Table 2.
Statistical analysis
Clinical data were collected from the patients' charts, ano-
nymised, and entered into a computerised database. Medians,
25th–75th percentiles (IQR), or percentages were calculated
for the overall sample and subgroups. Comparisons between
groups were made with the use of the Mann-Whitney U test or
the Fisher exact test, as appropriate. Repeated measures
within groups were compared with a Wilcoxon signed rank
sum test. Including all consecutive hemodynamic measure-
ments per patient, correlations between data pairs were
established using linear regression analysis and are expressed
Table 1
Baseline characteristics of patients on admission to the intensive care unit
Sepsis
n = 9
Acute heart failure
n = 12
P value
Gender, male/female 5/4 10/2 0.33
Age, years 52 (37–65) 65 (55–71) 0.15
Body mass index, kg/m2 23.4 (20.4–25.5) 25.0 (23.3–29.7) 0.19
SAPS II 49 (41–63) 35 (27–65) 0.19
PaO2/FiO2 ratio, mm Hg 165 (115–206) 254 (210–377) 0.004
ProBNP, ng/L 13,104 (6,964–27,225) 13,822 (7,692–23,885) 0.92
Troponin T, μg/L 0.03 (0.01–0.40) 0.11 (0.03–2.57) 0.42
Creatinine, μmol/L 129 (97–215) 138 (114–191) 0.65
White blood cell count, per mm3 12.5 (9.7–18.8) 9.5 (7.3–12.6) 0.19
CRP, mg/L 244 (85–334) 28 (7–150) 0.006
PCT, ng/mL 18.0 (2.5–34.4) 0.3 (0.2–1.3) 0.001
LVEFa, percentage 60 (50–65) 28 (19–43) 0.005
Data are presented as numbers or medians (interquartile ranges). Creatinine, norm 70 to 105 μmol/L. Troponin T, norm <0.10 μg/L. 
aEchocardiography was performed in seven patients with sepsis and in nine patients with acute heart failure. CRP: C-reactive protein (norm <5 
mg/L); FiO2: inspired oxygen fraction; LVEF: left ventricular ejection fraction; PaO2: partial arterial oxygen pressure; PCT: procalcitonin (norm <0.5 
ng/mL); ProBNP: N-terminal pro-B-type natriuretic peptide (norm <227 ng/L); SAPS II: Simplified Acute Physiology Score II.Page 3 of 10
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investigate the relationship between the cardiac index meas-
ured by PAC and PiCCO, bias and limits of agreement of data
pairs were calculated as described by Bland and Altman [35].
Bias represents the systemic error between the two methods.
Upper and lower limits of agreement, calculated as mean bias
± two standard deviations, define the range in which 95% of
the differences are expected. The percentage error was calcu-
lated as 100 × (CO indexed for body surface area [CI] by
PiCCO - CI by PAC)/[(CI by PiCCO + CI by PAC)/2], as pro-
posed by Rödig and colleagues [36]. All analyses were per-
formed using SPSS version 12.0 for Windows (SPSS Inc.,
Chicago, IL, USA). Statistical significance was defined as P
values of below 0.05, and all hypothesis testing was two-
tailed.
Results
The clinical characteristics of the two study groups are
described above. Net fluid balance during the 24-hour obser-
vation period was +2,066 (375 to 2,749) mL in septic patients
as compared with +60 (-596 to 1,622) mL in patients with
AHF (P = 0.11). ICU lengths of stay were 17 (14 to 30) days
in septic patients and 12 (5 to 19) days in AHF patients (P =
0.13). Overall ICU mortality rates were 44% (4/9) among
patients with sepsis and 25% (3/12) among those with AHF
(P = 0.40).
Hemodynamic measurements
Measurement of PAOP was unavailable in two AHF patients,
and the SmvO2 was missing in another AHF patient. Hemody-
namic measurements obtained at the first and fourth record-
ings are shown in Table 3. Between the first and the forth
measurements, hemodynamic variables remained nearly
unchanged. Exceptions were LVSWI (increase in septic
patients), PAOP and GEDVI (decrease in AHF patients), and
SmvO2 (increase in AHF patients). According to the mild
changes during the observation period, we pooled the results
within each group for further correlation purposes (Table 4). In
comparison with patients with AHF, those with sepsis had
higher cardiac index, CP, LVSWI, SmvO2, CFI, GEF, PVPI,
and ELWI/GEDVI ratio but a lower PAOP. ELWI was higher in
patients with sepsis, but this trend did not reach statistical sig-
nificance (P = 0.09).
A Bland-Altman analysis of cardiac index measurements by
PiCCO and PAC resulted in a mean bias of 0.19 L/minute per
square metre. Limits of agreement were -0.97 and 1.35 L/
minute per square metre. The median percentage error of
comparisons was 2.5%. It was within 15% for 68% of compar-
isons between CI by PiCCO and CI by PAC. In septic patients,
r2 between the two cardiac indexes was 0.81 (P < 0.001)
compared with 0.58 in patients with AHF (P < 0.001).
Comparisons between CFI and other markers of cardiac per-
formance (CP and LVSWI) are displayed in Figure 1. Figure 1
demonstrates the significant correlation between CFI and
LVSWI (sepsis: r2 = 0.30, P = 0.001; AHF: r2 = 0.23, p =
0.002) as well as CFI and CP (sepsis: r2 = 0.39, P < 0.001;
AHF: r2 = 0.45, P < 0.001) in both patient groups. In Figures
1a and 1b, the CFI values of four septic patients with
depressed cardiac function can easily be identified. The corre-
lations between GEF and LVSWI (sepsis: r2 = 0.26, P =
0.001; AHF: r2 = 0.18, P = 0.006) plus GEF and CP (sepsis:
r2 = 0.22, P = 0.004; AHF: r2 = 0.13, P = 0.01), as shown in
Figure 2, were comparable to the corresponding CFI correla-
tions in Figure 1. The overall correlation between CFI and GEF
was r2 = 0.81 (P < 0.001). Figure 3 shows the relationships
between CFI and PAOP and between CFI and SmvO2. It dem-
onstrates the significant negative correlation between CFI and
PAOP (r2 = -0.18, P = 0.006) in AHF patients but not in
patients with sepsis (P = 0.89). On the other hand, CFI was
significantly correlated with SmvO2 in septic patients (r2 =
0.22, P = 0.004) but not in those with heart failure (P = 0.26).
All AHF patients had an SmvO2 of not more than 70% and a
CFI of less than 4.5 per minute, except one suffering from con-
genital heart disease, who presented with low central venous
oxygen saturation and shock. In this patient (classified as AHF
because of her history), PAC showed a CI of 3.6 L/minute per
square metre and an SmvO2 of 68%. PiCCO revealed a CFI
of at least 4.5 per minute in two of four measurements and a
GEF of greater than 20% in all four measurements.
All septic patients with cardiac dysfunction (CFI of less than
4.5 per minute) had an SmvO2 of not more than 70%. Among
Table 2
Definitions
LVSWI = SVI × (MAP – PAOP) × 0.0136
CP = MAP × CO/451
ITTV = CO × MTt
PTV = CO × DSt
GEDV = ITTV - PTV = CO × (MTt - DSt)
ITBV = 1.25 × GEDV
CFI = (CO/GEDV) × 103
GEF = SV/(GEDV/4)
EVLW = ITTV - ITBV
PVPI = EVLW/PBV
The detailed pathophysiological background is explained in Materials 
and methods. CFI: cardiac function index; CO: cardiac output; CP: 
cardiac power; DSt: exponential downslope time; EVLW: 
extravascular lung water; GEDV: global end-diastolic volume; GEF: 
global ejection fraction; ITBV: intrathoracic blood volume; ITTV: 
intrathoracic thermal volume; LVSWI: left ventricular stroke work 
index; MAP: mean arterial pressure; MTt: mean transit time; PAOP: 
pulmonary artery occlusion pressure; PBV: pulmonary blood volume; 
PTV: pulmonary thermal volume; PVPI: pulmonary vascular 
permeability index; SV: stroke volume; SVI: stroke volume indexed for 
body surface area.Page 4 of 10
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Available online http://ccforum.com/content/13/4/R133those with a CFI of at least 4.5 per minute, 1 patient had four
SmvO2 values of less than 70%, most likely because of hypo-
volemia. The remaining four points of less than 70% (2
patients) were associated with an arterial oxygen saturation of
below 92% (Figure 3b).
PAOP did not correlate with ELWI and PVPI either in septic or
in heart failure patients (Figure 4). Five of 12 patients with AHF
and 6 of 9 with sepsis had at least one PVPI value of greater
than 3.0, indicating that PVPI may not discriminate between
heart failure and sepsis. No correlations were found between
PAOP and GEDVI (data not shown).
Discussion
The results of the present study indicate that in patients with
AHF and severe sepsis or septic shock the PiCCO-derived
cardiac function parameters, namely CFI and GEF, are valua-
ble and comparable to the more classic PAC-derived parame-
ters such as CP and LVSWI and are better than PAOP and
SmvO2. In patients with sepsis, the PVPI and the ratio of ELWI
to GEDVI were only slightly higher than in those with AHF,
which suggests an increased pulmonary vascular permeability
in the latter group. Elevated ELWI despite a relatively low
PAOP for patients with AHF supports this assumption.
Table 3
Comparing the first and the fourth hemodynamic measurements in patients with sepsis and acute heart failure
Sepsis Acute heart failure
1st measurement 4th measurement 1st measurement 4th measurement
n = 9 n = 9 n = 12 n = 12
Basic monitoring
Heart rate, 1/minute 83 (80–96) 90 (78–108) 87 (72–97) 85 (75–95)
MAP, mm Hg 75 (65–81) 77 (69–86) 74 (70–78) 66 (58–75)a, b
RAP, mm Hg 13 (9.0–17) 12 (10–15) 13 (9.5–15) 11 (8.3–15)
SaO2, percentage 94 (91–96) 94 (93–97) 95 (94–96) 94 (93–97)
PAC
CI, L/minute per m2 3.8 (3.1–4.3) 4.8 (3.7–6.2) 2.6 (1.9–3.1)a 2.8 (2.3–3.1)a
CP, W 1.00 (0.88–1.32) 1.33 (1.04–1.87) 0.71 (0.59–0.95) 0.80 (0.65–0.93)a
LVSWI, g-m/m2 32 (23–45) 42 (34–54)b 20 (17–25)a, c 18 (17–29)a, c
MPAP, mm Hg 31 (30–32) 27 (27–31) 32 (27–37) 31 (22–35)
PAOP, mm Hg 18 (15–21) 17 (14–18) 21 (17–26)c 19 (12–20)b, c
SmvO2, percentage 68 (61–74) 70 (60–75) 50 (48–62)a, d 59 (52–64)a, b, d
PiCCO
CI, L/minute per m2 3.6 (3.5–5.6) 4.8 (3.8–5.4) 2.9 (1.8–3.8)a 2.9 (2.2–3.3)a
CFI, 1/minute 6.0 (3.3–6.8) 6.4 (3.5–8.0) 2.7 (2.2–2.9)a 2.7 (2.4–3.6)a
GEF, percentage 21 (15–30) 25 (16–34) 13 (9.8–14)a 14 (12–17)a
GEDVI, mL/m2 857 (703–1,128) 797 (660–1,164) 1,141 (893–1,311)a 904 (796–1,144)b
ELWI, mL/kg 18.2 (14.7–24.0) 15.3 (12.4–20.2) 15.4 (13.7–22.4) 15.7 (14.0–19.2)
PVPI 2.6 (2.2–4.1) 3.0 (1.9–3.4) 2.8 (2.0–3.8) 2.5 (1.9–2.8)
ELWI/GEDVI, × 102 2.0 (1.6–2.7) 2.1 (1.4–2.3) 1.6 (1.2–2.4) 1.9 (1.4–2.2)
The results are presented as medians (interquartile ranges). aP < 0.05 between the two groups for a given time point; bP < 0.05 for changes 
between the two time points within a group. Reduced numbers because of missing data are indicated by superscript c (c), where n = 10, and 
superscript d (d), where n = 11. CFI: cardiac function index; CI: cardiac index; CP: cardiac power; ELWI: extravascular lung water index; GEDVI: 
global end-diastolic volume index; GEF: global ejection fraction; LVSWI: left ventricular stroke work index; MAP: mean arterial pressure; MPAP: 
mean pulmonary arterial pressure; PAC: pulmonary artery catheter; PAOP: pulmonary artery occlusion pressure; PiCCO: transpulmonary 
thermodilution technique; PVPI: pulmonary vascular permeability index; RAP: right atrial pressure; SaO2: arterial oxygen saturation; SmvO2: mixed 
venous oxygen saturation.Page 5 of 10
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parallel values obtained by PAC [20,37,38]. In addition to pre-
vious reports from surgical and septic patients, our data prove
that this is also the case for critically ill medical patients pre-
senting with AHF and a low CO. The systemic error (bias) of
CO measurements between PiCCO and PAC was considera-
bly lower in our medical ICU population. As previously
reported, CO is usually slightly overestimated when measured
in the aorta compared with the pulmonary artery [20,39].
SmvO2 is considered a surrogate marker of CO in several con-
ditions [40]. In our study, we found that SmvO2 correlated with
CFI in patients with sepsis but not in those with AHF. All
patients presenting with AHF had an SmvO2 of below 70%.
Among the septic patients with a CFI of greater than 4.5 per
minute, three had SmvO2 measurements of below 70%. This
observation is in line with the hypothesis that SmvO2 has a low
sensitivity and specificity for the detection of myocardial dys-
function in patients with distributive shock [41-43]. Our results
favour CO measurements over SmvO2 assessments for the
monitoring of cardiac performance in septic patients.
PAC-derived LVSWI and particularly CP, the product of CO
and MAP, are predictors of outcome in cardiogenic shock
patients [32-34]. In our study, we found a good correlation
between CFI and both LVSWI and CP, independently of
whether patients had sepsis or AHF. Of note, the median left
ventricular ejection fractions were below 30% in heart failure
patients and normal in septic patients. The PiCCO parameters
CFI and GEF have previously been shown to be reliable mark-
ers of left ventricular function when compared with echocardi-
ographic assessments [27] and left ventricular dP/dt max [44].
Interestingly, CFI and GEF identified a subpopulation of septic
patients with a myocardial function as poor as in AHF patients.
The CFI cutoff level for a depressed myocardial function in our
septic population was between 4 and 5 per minute, which is
in agreement with the results of a recent study indicating that
a CFI of less than 4 per minute estimated a left ventricular frac-
tional area of change of less than 40% with a sensitivity of
86% and a specificity of 88% [30].
In AHF patients but not in septic patients, PAOP was nega-
tively correlated with CFI, suggesting that PAOP in heart fail-
ure is a marker of myocardial dysfunction. This is in line with
earlier results in patients with acute myocardial infarction [45],
in which a PAOP of at least 18 mm Hg was associated with an
increased mortality [46]. Caution is recommended when using
PAOP as a surrogate marker of cardiac function because
Table 4
Comparing hemodynamic characteristics between patients with sepsis and acute heart failure
Sepsis
n = 36
Acute heart failure
n = 48
P value
PAC
CI, L/minute per m2 4.2 (3.6–5.5) 2.6 (2.2–3.0) < 0.001
CP, W 1.14 (0.99–1.63) 0.80 (0.62–0.94) < 0.001
LVSWI, g-m/m2 38 (30–49) 23 (18–29)a < 0.001
RAP, mm Hg 13 (9–15) 12 (8–14) 0.26
PAOP, mm Hg 16 (15–18) 20 (15–24)a 0.008
MPAP, mm Hg 29 (26–32) 32 (26–37) 0.02
SmvO2, percentage 68 (62–74) 57 (50–62)b < 0.001
PiCCO
CI, L/minute per m2 4.6 (3.7–5.6) 2.7 (2.2–3.3) < 0.001
CFI, 1/minute 6.1 (3.5–6.8) 2.8 (2.3–3.1) < 0.001
GEF, percentage 23 (17–30) 14 (10–16) < 0.001
GEDVI, mL/m2 907 (748–1133) 995 (849–1172) 0.16
ELWI, mL/kg 18.0 (14.3–23.1) 14.7 (13.1–18.5) 0.09
PVPI 2.8 (2.3–3.5) 2.4 (1.7–2.9) 0.01
ELWI/GEDVI, × 102 2.0 (1.7–2.4) 1.6 (1.3–2.2) 0.01
Data represent the median (interquartile range) of the four consecutive measurements obtained during the observation period. Reduced numbers 
because of missing values are indicated with superscript a (a), where n = 40, and superscript b (b), where n = 44. CFI: cardiac function index; CI: 
cardiac index; CP: cardiac power; ELWI: extravascular lung water index; GEDVI: global end-diastolic volume index; GEF: global ejection fraction; 
LVSWI: left ventricular stroke work index; MPAP: mean pulmonary arterial pressure; PAC: pulmonary artery catheter; PAOP: pulmonary artery 
occlusion pressure; PiCCO: transpulmonary thermodilution technique; PVPI: pulmonary vascular permeability index; RAP: right atrial pressure; 
SmvO2: mixed venous oxygen saturation.Page 6 of 10
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ance. Hence, the relationship between the left ventricular filling
pressure and volume is not linear [47]. Therefore, other pres-
sure-independent hemodynamic markers of cardiac function
such as CFI, GEF, or CP are superior. The results of our study
in septic and AHF patients suggest that CFI adequately
reflects cardiac function and may be preferred to PAOP,
LVSWI, and CP.
Consistent with previous studies in heart failure [8] and septic
[48,49] patients, PAOP correlated neither with GEDVI nor
with EVLW. In contrast to a recent study performed in patients
with hydrostatic pulmonary edema and acute lung injury/acute
respiratory distress syndrome (ALI/ARDS) [13], we could not
find a significant difference in GEDVI and EVLW between
heart failure and septic patients. However, we found a lower
PVPI and ELWI/GEDVI ratio in patients with AHF than in those
with sepsis. This is in accordance with the hydrostatic origin of
pulmonary edema in the former group. In our septic patients,
GEDVI was higher and ELWI and PVPI were both lower than
in the patients with ALI/ARDS reported by Monnet and col-
leagues [13]. This difference may be explained by lower pul-
monary vascular permeability and milder pulmonary edema in
our patients. The PaO2/FiO2 (partial arterial oxygen pressure/
inspired oxygen fraction) ratios were an average of 165 mm
Hg in our septic patients and 118 mm Hg in patients with ALI/
ARDS reported by Monnet and colleagues. In our AHF
patients, PVPI and the ELWI/GEDVI ratio were surprisingly
high, suggesting an increased pulmonary vascular permeabil-
ity in addition to an elevated left ventricular filling pressure.
These results add further evidence against the use of PAOP
as the only criterion to differentiate between a hydrostatic and
a permeability type of pulmonary edema [12,50,51].
The number of patients limits the results of our study. How-
ever, consistently using four measurements per patient in a
condition close to a steady state over a short observation
period of an average of 19 hours, 2 days after ICU admission,
Figure 1
The relation between CFI, LVSWI and CP. (a) The relationship 
between cardiac function index (CFI) and left ventricular stroke work 
index (LVSWI) in patients with sepsis and those with acute heart fail-
ure. Significant correlations between the two variables exist in patients 
with sepsis (r2 = 0.30, P = 0.001) and those with acute heart failure (r2 
= 0.23, P = 0.002). (b) The significant relationship between CFI and 
cardiac power (CP) in both patient groups (sepsis: r2 = 0.39, P < 
0.001; acute heart failure: r2 = 0.45, P < 0.001). Dashed lines indicate 
CFI of 4.5 per minute, LVSWI of 40 g-m/m2, and CP of 1.3 W.
Figure 2
The relation between GEF, LVSWI and CP. (a) The relationship 
between global ejection fraction (GEF) and left ventricular stroke work 
index (LVSWI) in patients with sepsis and those with acute heart fail-
ure. Significant correlations between the two variables exist in patients 
with sepsis (r2 = 0.26, P = 0.001) and those with acute heart failure (r2 
= 0.18, P = 0.006). (b) The significant relationship between GEF and 
cardiac power (CP) in both patient groups (sepsis: r2 = 0.22, P = 
0.004; acute heart failure: r2 = 0.13, P = 0.01). Dashed lines indicate 
GEF of 20%, LVSWI of 40 g-m/m2, and CP of 1.3 W.Page 7 of 10
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consecutive measurements in the same patients may have
multiplied the number of errors. However, as seen in Tables 3
and 4, the IQRs for a single variable between the four sets of
measurements and within the groups were small. Thus, our
measurements made in two different and well-characterised
clinical conditions probably give a realistic hemodynamic pic-
ture of the two populations, allowing a fair comparison
between PiCCO and PAC. Another important point is that
some of the investigated parameters are mathematically cou-
pled. For example, LVSWI, CFI, and CP are all linked to SV.
Similarly, GEDV is the preload index for both CFI and GEF.
This fact might explain at least some of the significant correla-
tions found in this study.
Conclusions
The results of our study indicate that hemodynamic variables
derived from the transpulmonary thermodilution method allow
hemodynamic characterisation of patients with AHF and sep-
sis. In particular, a low CFI and GEF identified cardiac dysfunc-
tion in patients with AHF and in patients with severe sepsis or
septic shock. Prospective studies are now needed to demon-
strate that the PiCCO technology is superior to a standard of
care based on the current recommendations for hemodynamic
monitoring and management in shock [40,52].
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